MovDisordV3, Main, Exploration, bibRecord, 001480

Parkinsonism and dystonia associated with adalimumab

Identifieur interne : 001480 ( Main/Exploration ); précédent : 001479; suivant : 001481

Parkinsonism and dystonia associated with adalimumab

Auteurs : Ainhi D. Ha [États-Unis] ; Joseph Jankovic [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2011-07.

RBID : ISTEX:B8163251730A3E7ED510F447E6D8F8473C5634E6

Descripteurs français

Pascal (Inist)
- Adalimumab, Dystonie, Parkinsonisme, Pathologie du système nerveux.

English descriptors

KwdEn :
- Adalimumab, Adolescent, Adult, Aged, Antibodies, Monoclonal, Humanized (adverse effects), Arthritis, Rheumatoid (drug therapy), Brain (pathology), Dystonia, Dystonia (diagnosis), Dystonia (etiology), Female, Humans, Magnetic Resonance Imaging, Nervous system diseases, Parkinsonian Disorders (diagnosis), Parkinsonian Disorders (etiology), Parkinsonism, Tumor Necrosis Factor-alpha (antagonists & inhibitors).
MESH :
- chemical , adverse effects : Antibodies, Monoclonal, Humanized.
- chemical , antagonists & inhibitors : Tumor Necrosis Factor-alpha.
- diagnosis : Dystonia, Parkinsonian Disorders.
- drug therapy : Arthritis, Rheumatoid.
- etiology : Dystonia, Parkinsonian Disorders.
- pathology : Brain.
- Adolescent, Adult, Aged, Female, Humans, Magnetic Resonance Imaging.

Url:

https://api.istex.fr/document/B8163251730A3E7ED510F447E6D8F8473C5634E6/fulltext/pdf

DOI: 10.1002/mds.23548

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinsonism and dystonia associated with adalimumab</title>
<author><name sortKey="Ha, Ainhi D" sort="Ha, Ainhi D" uniqKey="Ha A" first="Ainhi D." last="Ha">Ainhi D. Ha</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B8163251730A3E7ED510F447E6D8F8473C5634E6</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23548</idno>
<idno type="url">https://api.istex.fr/document/B8163251730A3E7ED510F447E6D8F8473C5634E6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002809</idno>
<idno type="wicri:Area/Istex/Curation">002809</idno>
<idno type="wicri:Area/Istex/Checkpoint">000212</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Ha A:parkinsonism:and:dystonia</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:21495070</idno>
<idno type="wicri:Area/PubMed/Corpus">001284</idno>
<idno type="wicri:Area/PubMed/Curation">001284</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001171</idno>
<idno type="wicri:Area/Ncbi/Merge">003143</idno>
<idno type="wicri:Area/Ncbi/Curation">003143</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003143</idno>
<idno type="wicri:Area/Main/Merge">001533</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:11-0353378</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000525</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002793</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000461</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Ha A:parkinsonism:and:dystonia</idno>
<idno type="wicri:Area/Main/Merge">001A51</idno>
<idno type="wicri:Area/Main/Curation">001480</idno>
<idno type="wicri:Area/Main/Exploration">001480</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkinsonism and dystonia associated with adalimumab</title>
<author><name sortKey="Ha, Ainhi D" sort="Ha, Ainhi D" uniqKey="Ha A" first="Ainhi D." last="Ha">Ainhi D. Ha</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-07">2011-07</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1556">1556</biblScope>
<biblScope unit="page" to="1558">1558</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">B8163251730A3E7ED510F447E6D8F8473C5634E6</idno>
<idno type="DOI">10.1002/mds.23548</idno>
<idno type="ArticleID">MDS23548</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adalimumab</term>
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Antibodies, Monoclonal, Humanized (adverse effects)</term>
<term>Arthritis, Rheumatoid (drug therapy)</term>
<term>Brain (pathology)</term>
<term>Dystonia</term>
<term>Dystonia (diagnosis)</term>
<term>Dystonia (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Nervous system diseases</term>
<term>Parkinsonian Disorders (diagnosis)</term>
<term>Parkinsonian Disorders (etiology)</term>
<term>Parkinsonism</term>
<term>Tumor Necrosis Factor-alpha (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dystonia</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dystonia</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adalimumab</term>
<term>Dystonie</term>
<term>Parkinsonisme</term>
<term>Pathologie du   système nerveux</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
<settlement><li>Houston</li>
</settlement>
<orgName><li>Baylor College of Medicine</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Ha, Ainhi D" sort="Ha, Ainhi D" uniqKey="Ha A" first="Ainhi D." last="Ha">Ainhi D. Ha</name>
</region>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001480 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001480 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B8163251730A3E7ED510F447E6D8F8473C5634E6
   |texte=   Parkinsonism and dystonia associated with adalimumab
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Parkinsonism and dystonia associated with adalimumab

Parkinsonism and dystonia associated with adalimumab

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.